Heal / Drug / Drugs / Clinical / Research

Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model

Posted on: Sep 16, 2020   |   Posted by: Biotech Mag

Infliximab , a TNF-α blocking chimeric monoclonal antibody, induces clinical response and mucosal healing in patients with inflammatory bowel disease. However, systemic...

Other Posts from Biotech Mag